期刊文献+

低剂量肝素联合前列腺素E1预防重型β-地中海贫血患儿异基因造血干细胞移植后的肝静脉阻塞病 被引量:3

Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with β-thalassemia major
暂未订购
导出
摘要 目的研究低剂量肝素联合前列腺素E1(PGE1)预防重型β-地中海贫血患儿异基因造血干细胞移植后的肝静脉阻塞病(hepatic veno-occlusive disease,HVOD)的临床效果。方法43例重型β-地中海贫血患儿接受异基因造血干细胞移植,研究组给予肝素钠每日100IU/kg,24h微量泵维持静脉注射,PGE1每日7.2μg/kg,输液泵持续静脉输注10h以上;对照组给予PGE1每日7.2μg/kg,输液泵持续静脉输注10h以上,两组均用至移植后第30天,以预防HVOD。结果研究组6例发生HVOD(6/23,26.1%),其中3例轻度、3例中度;对照组12例发生HVOD(12/20,60.0%),其中3例轻度、3例中度、6例重度。研究组HVOD的发生率低于对照组,差异具有统计学意义(P<0.05)。经治疗后研究组5例治愈,1例死于其他并发症,对照组10例治愈,2例死亡。两种预防方案在使用过程中均未出现明显的药物毒副反应。结论该研究所采用的低剂量肝素钠+PGE1预防HVOD的方案比单独采用PGE1更有效。 Objective Hepatic veno-occlusive disease (HVOD) is one of the most serious complications after allogenic hematopoietic stem cell transplantation (allo-SCT). Endothelial injury, leading to deposition of coagulation factous in the terminal hepatic venules, is believed to the key event in the pathogenesis of HVOD. This study was designed to explore the efficacy of low-dose heparin and prostaglandin E1 ( PGE1 ) in the prevention of HVOD after allo-SCT in children with β-thalassemia major. Methods Forty-three children with β-thalassemia major received allo-SCT. For the prevention of HVOD, 23 of the 43 patients received low-dose heparin (100 IU/kg· d) and also received PGE1 (7.2 μg/kg ·d) by continuous intravenous infusion ( study group ) from the beginning of conditioning treatment to the 30th day after allo-SCT. Patients who received continuous infusions of PGE1 (7.2 μg/kg ·d) alone were used as the control group ( n = 20). Results HVOD occurred in 6 patients ( 26. 1% ) in the study group ( 3 mild, 3 moderate). Twelve patients in the control group had HVOD (60.0%) (3 mild, 3 moderate, 6 severe) ( P 〈 0.05 ). In the study group, 5 cases of HVOD were treated successfully and one died from other complications. Of the 12 cases of HVOD in the control group, 10 patients were treated successfully and two patients died from HVOD. There were no obvious drug adverse effects in the two groups. Conclusions Low-dose heparin and PGE1 is more effective than PGE1 alone for the prevention of HVOD after allo-SCT.
出处 《中国当代儿科杂志》 CAS CSCD 2007年第4期343-346,共4页 Chinese Journal of Contemporary Pediatrics
关键词 肝素 前列腺素E1 肝静脉阻塞病 异基因造血干细胞移植 儿童 Heparin Prostaglandin E1 Hepatic veno-occlusive disease Allogenic hematopoietic stem cell trans-plantation Child
  • 相关文献

参考文献16

  • 1Lucarelli G,Galimberti M,Polehi P,Anqelucci E,Baronciani D,Giardini C,et al.Bone marrow transplantation in patients with thalassemia[J].New Engl J Med,1990,322(7):417-421.
  • 2曹履先,王波,刘惠兰.骨髓移植早期的其他并发症[M].//曹履先.临床骨髓移植.北京:军事医学科学出版社,1999,61-64.
  • 3Imran H,Tlejeh IM,Zirakzadeh A,Rodriguez V,Khan SP.Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation:a systematic review and meta analysis[J].Bone Marrow Transplant,2006,37 (7):677-686.
  • 4Cesaro S,Pillon M,Talenti E,Toffolutti T,Callore E,Tridello G,et al.A prospective survey on incidence,risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation[J].Haematologica,2005,90(10):1396-1404.
  • 5McDonald GB,Hinds MS,Fisher LD,Schoch HG,Wolford JL,Banaji M,et al.Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation:A cohort study of 355 patients[J].Ann Intrn Med,1993,118(4):255-267.
  • 6Shulman HM,Hinterberger W.Hepatic veno-occlusive diseaseliver toxicity syndrome after bone marrow transplantation[J].Bone Marrow Transplant,1992,10(3):197-214.
  • 7Carreras E,Granena A,Rozman C.Hepatic veno-occlusive disease after bone marrow transplantation[J].Blood Rev,1993,7(1):43-51.
  • 8Shulman HM,Fisher LB,Schoch HG,Henne KW,McDonald GB.Veno-occlusive disease of the liver after marrow transplantation:histological correlates of clinical signs and symptoms[J].Hepatology,1994,19 (5):1171-1180.
  • 9Ho V,Momtaz P,Didas C,Wadleigh M,Richardson P.Posttransplant hepatic veno-occlusive disease:pathogenesis,diagnosis and treatment[J].Rev Clin Exp Hematol,2004,8(1):E3.
  • 10Wadleigh M,Ho V,Momtaz P,Richardson P.Hepatic veno-occlusive disease:pathogenesis,diagnosis and treatment[J].Curr Opin Hematol,2003,10(6):451-462.

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部